News‎ > ‎Full Stories‎ > ‎

13 October 2017

posted Oct 13, 2017, 12:25 AM by Beck Lockwood   [ updated Oct 13, 2017, 6:09 AM ]
DEC researchers take part in Canadian Precision Medicine Policy workshop

Health economics researchers from NIHR DEC Leeds have been invited to take part in a workshop on precision medicine organised by the Genome Canada Precision Medicine Policy Network.

The event will focus on ‘Uncertainty in the Value Assessment of Precision Medicine’, examining best practice in identifying, quantifying and synthesizing uncertainty in the evidence base for the value of precision medicine technologies.

Health economics and statistical experts from the UK and Canada, along with clinicians and policy makers will share best practice, identify remaining challenges, and explore opportunities for future collaborations.

Participants will consider, in particular, the issues around uncertainty in the evidence for laboratory, therapeutics, patient and public values, and clinical implementation of precision medicine technologies.

Dr Bethany Shinkins, and Alison Smith will discuss health economic evaluation of medical tests.

“We’re excited to participate and present at this international workshop on Uncertainty in Precision Medicine,” says Dr Shinkins. “We have a fantastic collaborative relationship with Prof Chris McCabe and his group in Canada, and this workshop will enable us to identify key research priorities in the economic evaluation of precision medicine technologies and explore additional opportunities to work together”.